Skip to main content
OpenTrials
Completed

NCT Number: NCT03628794

Digital Supportive Care Awareness & Navigation

To pilot test the feasibility, usability, and preliminary efficacy of the D-SCAN mobile application in cancer patients and caregivers at Duke.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Duke University Cancer Center

Durham, North Carolina, 27705, United States

About this study

D-SCAN, a digital patient navigator service in the form of a mobile application ("app"), has been designed at Duke, with feedback from Duke Cancer Institute (DCI) patients, caregivers and clinicians (screenshots in Appendix A).3 Its purpose is to facilitate awareness of available Cancer Patient Support Program (CPSP) services at Duke, and to also help patients recognize their unmet symptom management needs by answering questions from the Edmonton Symptom Assessment Scale (ESAS). This novel electronic system helps to connect patients and their loved ones with existing resources tailored to their unique situations, ensuring that no supportive care needs go unaddressed, thus improving patients' lives and their cancer care.

This protocol aims to assess the feasibility, usability, and preliminary efficacy of the D-SCAN mobile application. The app data, along with quantitative and qualitative feedback obtained during the pilot, will inform future development and design of a subsequent efficacy trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who are at least age 18
  • Patients who have the capacity to give consent
  • Patients with advanced cancer who have initiated treatment at the DCI in the last 12 weeks
  • Caregivers over the age of 18 caring for either enrolled or not enrolled patients with advanced cancer who have initiated treatment at the DCI in the last 12 weeks

Exclusion criteria

  • Patients who are too ill to participate (per clinician discretion)
  • Patients not able to read or understand English

Treatment and study plan

D-SCAN

Device

Subjects will receive a digital patient navigator service in the form of a mobile application ("app"), which has been designed at Duke, with feedback from Duke Cancer Institute (DCI) patients, caregivers and clinicians. Its purpose is to facilitate awareness of available Cancer Patient Support Program (CPSP) services at Duke, and to also help patients recognize their unmet symptom management needs. Subjects receiving the D-SCAN mobile app will also complete a survey every week within the app. The first 15 patients and 5 caregivers randomized into the intervention arm (those receiving the app) will also be asked to participate in a qualitative interview assessment at week 12, +/- 3 weeks

Primary outcomes

  1. Number of enrolled patients complete at least 3 of the 12 symptom surveys over the study duration

    Time frame: 12 weeks

  2. Number of patients who complete the exit survey

    Time frame: 12 weeks

  3. Number of patients who return the phone

    Time frame: 12 weeks

Secondary outcomes

  1. Frequency of use

    Time frame: 12 weeks

  2. Duration of use

    Time frame: 12 weeks

  3. Session Length

    Time frame: 12 weeks

  4. Number of content views

    Time frame: 12 weeks

  5. Number of actions taken

    Time frame: 12 weeks

Sponsors and collaborators

Lead sponsor

Duke University

Other

Collaborators

  • AstraZeneca

Registry information

Official study title

Pilot Testing the Digital Supportive Care Awareness & Navigation (D-SCAN) Application

Acronym: D-SCAN

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Aug 14, 2018
Registry last updated
Jul 18, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.